We appreciated reading the article by Zhang et al[1] about a retrospective study of 102 mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) patients with epilepsy in which disability and...
grants from the National Natural Science Foundation of China (No. 81671235 and No. 81701237);People's Benefit Project of Science and Technology in Qingdao (No. 16-6-2-1-nsh) and the Taishan Scholars Program of Shandong Province.
To the Editor: Mitochondrial encephalomyopathy with lactate acidosis and stroke-like episodes (MELAS) is one of the most common multisystem mitochondrial disorders with broad clinical manifestations.[1] It is usually ...
Support Projects of“Yangfan Plan”of Beijing Medical Administration (No.ZYLX201836);National Natural Science Foundation of China (No.NSFC81371201);Key projects of basic and clinical cooperation of Capital Medical University (No.16JL03);National Key Technology Research and Development Program of the Ministry of Science and Technology of The People's Republic of China (No.2015BAI12B04);National Key Technology Research and Developmenr Program of the Ministry of Science and Technology of The People's Republic of China (No.2015BAI12B02);Beijing Institute For Brain Disorders (No.1152130306);Beijing Municipal Administration of Hospitals' Mission Plan (No.SML20150502).
Mitochondrial encephalomyopathy with lactic acidosis and strokelike episodes (MELAS) is a metabolic disorder characterized by hyperlactic acidemia and stroke-like symptoms.